Health authorities are launching a major vaccination effort targeting frontline workers, with plans to administer a jab designed for a different strain of Ebola. The initiative includes a one-year clinical trial enrolling a portion of the participants, aiming to assess both safety and effectiveness in a high-risk population. While the vaccine was developed for a distinct Ebola variant, officials hope it may offer cross-protection against current outbreaks. The move underscores growing concerns over the virus’s spread and the urgent need for preventive measures in vulnerable regions.
50,000 frontline staff to receive a jab for a different Ebola strain, with 20,000 enrolled in a one-year clinical trial.
